UK designates first notified body for IVDs (In Vitro Diagnostics)
This article was originally published in Clinica
Executive Summary
UL International (UK) has become the first testing organisation to be designated by the Medical Devices Agency as a notified body for products covered by the In Vitro Diagnostics Directive. It has been designated for full quality assurance assessment (annex IV) of rubella, toxoplasmosis, cytomegaolvirus and chlamydia tests.